Morgan Stanley Begins Coverage on Denali Therapeutics (NASDAQ:DNLI)
Morgan Stanley assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report published on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $33.00 price objective on the stock. Several other equities analysts also recently issued reports on DNLI. Robert W. Baird initiated coverage on Denali Therapeutics in […]
Morgan Stanley assumed coverage on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report published on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $33.00 price objective on the stock. Several other equities analysts also recently issued reports on DNLI. Robert W. Baird initiated coverage on Denali Therapeutics in […]
